2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow De Motu Cordis: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants. Epinephrine, Placebo - Anaphylactic Reaction | Phase 1 | Completed | De Motu Cordis | 24 | 2023-10-24 | 2024-08-20 |
| Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults EpiPen ®., Epinephrine (0.3mg) inhaled, Epinephrine (1.3mg) - Anaphylactic Reaction | Phase 1 | Completed | De Motu Cordis | 23 | 2022-01-06 | 2023-07-24 |
Anaphylaxis (2)
Epinephrine (2) · Inhalation (1)
Australia (2)
Peter O'Neil (1) · Peter O'Neill (1)